Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey

NCT04067583 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT04067583
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067583 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Physician Knowledge of Safety and Safe Use Information for Aflibercept Administered by Intravitreal Injection in Europe: A Follow-up Physician Survey
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
October 8, 2019
Completion date
April 23, 2020
Enrollment
454 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ophthalmology, macular degeneration